FHLC
Fidelity MSCI Health Care Index ETF · PSE
- Category Health Care
- Expense Ratio 0.08%
- Listing Date Oct 24, 2013
- Volume 187,224.0
- Market Cap (AUM) $2,626.21M
Performance
-2.37%
1W
-2.06%
1M
-10.65%
3M
-3.41%
6M
+2.57%
YTD
+5.74%
1Y
Top Holdings
Technical Analysis of FHLC 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-01-04 12:00
- 2020-01-23 22:05
What Lies Ahead for Healthcare ETFs in Q4 Earnings?(Yahoo Finance)
- 2019-10-20 23:00
What's in Store for Healthcare ETFs in Q3 Earnings?(Yahoo Finance)
- 2019-09-05 03:36
6 Best Health Care Funds for a Volatile Market(Yahoo Finance)
- 2019-07-22 16:45
Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy(Yahoo Finance)
- 2019-07-21 22:55
Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy(Yahoo Finance)
- 2019-04-17 22:59
Can Q1 Earnings Lift Healthcare ETFs Higher?(Yahoo Finance)
- 2019-03-04 23:04
The 7 Best Healthcare ETFs for a Sector Rebound(Yahoo Finance)
- 2019-01-23 21:59
Healthcare ETFs in Focus Ahead of Q4 Earnings(Yahoo Finance)
- 2018-12-27 20:27
Healthcare and Value: 2 ETFs to Watch on Outsized Volume(Yahoo Finance)
- 2018-10-02 03:15
The 7 Best ETFs of the Third Quarter(Yahoo Finance)
- 2018-08-13 18:00
- 2018-08-03 03:27
- 2018-04-17 05:02
Tech Advances Could Help Healthcare ETFs Grow(Yahoo Finance)
- 2018-04-16 23:49
7 Sector ETFs to Own Now(Yahoo Finance)
- 2018-04-03 02:59
Fidelity Trims Fees on 3 Bond ETFs(Yahoo Finance)
- 2018-03-12 03:54
Market Correction May Foreshadow Bullish Run for Stock ETFs(Yahoo Finance)
- 2017-11-05 20:02
The 4 Most Promising ETFs for 2017 (XLF, FHLC)(Investopedia)
- 2017-10-24 04:09
What Analysts Recommend for Merck ahead of 3Q17 Earnings(Marketrealist)
- 2017-09-12 19:37
Must-Know Recent Developments for Gilead(Marketrealist)
- 2017-09-07 22:37
Inside Mercks Segment-Wise Performance in 2Q17(Marketrealist)
- 2017-08-31 04:36
Eli Lilly & Co.s Revenues in 2Q17(Marketrealist)
- 2017-08-29 04:35
Bristol-Myers Squibbs Oncology Products in 2Q17(Marketrealist)
- 2017-08-28 22:39
Johnson & Johnsons Consumer Segment in 2Q17(Marketrealist)
- 2017-08-22 19:37
How Allergans International Segment Performed in 2Q17(Marketrealist)
- 2017-08-14 19:36
Pfizers Declining-Revenue Products in 2Q17(Marketrealist)
- 2017-07-31 22:36
Eli Lillys Major Developments in 2Q17(Marketrealist)
- 2017-07-31 19:41
Pfizer on the Street: Analyst Recommendations after 2Q17(Marketrealist)
- 2017-07-26 06:06
Analysts Recommendations for Bristol-Myers Squibb in 2Q17(Marketrealist)
- 2017-07-23 22:11
Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs(Yahoo Finance)
- 2017-07-23 21:08
Johnson & Johnson: Medical Devices in 2Q17(Marketrealist)
- 2017-07-18 23:55
J&J Brightens Outlook: Healthcare ETFs in Focus(Yahoo Finance)
- 2017-07-16 21:07
Johnson & Johnsons 2Q17 Estimates: Medical Devices(Marketrealist)
- 2017-07-09 19:39
How 2Q17 Is Shaping Up for Pfizer(Marketrealist)
- 2017-07-03 21:08
Johnson & Johnsons Segment-Wise Performance in 1Q17(Marketrealist)
- 2017-07-02 19:38
Merck & Co. Reported 1% Growth in Its 1Q17 Revenues(Marketrealist)
- 2017-06-26 19:38
Tanezumab Receives FDA Fast Track Designation(Marketrealist)
- 2017-06-20 03:36
Updates on the Adcetris and Opdivo Combination(Marketrealist)
- 2017-06-18 19:36
How Eli Lillys Taltz Performed in Clinical Trials(Marketrealist)
- 2017-06-12 19:36
Akcea Therapeutics Volanesorsen: 1Q17 Performance(Marketrealist)
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.